Table 1 Characteristics of PD patients and healthy controls.

From: Impact of vitamin D3 supplementation on motor functionality and the immune response in Parkinson’s disease patients with vitamin D deficiency

 

PD Group

(n = 51)

HC Group

(n = 50)

Sex

M: 29

W: 22

M: 26

W: 24

Age

69.6 ± 11.0

65.3 ± 10.9

Disease duration

5.8 ± 4.1

 

LEDD, mg/d

513 ± 280

 

H-Y

2.32 ± 0.90

–

UPDRS

45.76 ± 23.06

–

UPDRS-III

26.35 ± 13.56

–

Breg

43.45 ± 12.18

–

MMSE

21.46 ± 7.07

–

MoCA

18.32 ± 7.51

–

SDS

45.85 ± 13.47

–

SAS

44.20 ± 12.50

–

PDSS

100.82 ± 23.48

–

  1. LEDD levodopa equivalent daily dose.
Back to article page